Global Diagnostics of Peripheral Arterial Disease Market Growth (Status and Outlook) 2023-2029

Global Diagnostics of Peripheral Arterial Disease Market Growth (Status and Outlook) 2023-2029

Peripheral arterial disease (PAD), also known as peripheral vascular disease or peripheral artery disease, is plaque buildup in your leg arteries that carry oxygen and nutrient-rich blood from your heart to your arms and legs.

LPI (LP Information)' newest research report, the “Diagnostics of Peripheral Arterial Disease Industry Forecast” looks at past sales and reviews total world Diagnostics of Peripheral Arterial Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostics of Peripheral Arterial Disease sales for 2023 through 2029. With Diagnostics of Peripheral Arterial Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostics of Peripheral Arterial Disease industry.

This Insight Report provides a comprehensive analysis of the global Diagnostics of Peripheral Arterial Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostics of Peripheral Arterial Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diagnostics of Peripheral Arterial Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostics of Peripheral Arterial Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostics of Peripheral Arterial Disease.

The global Diagnostics of Peripheral Arterial Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Diagnostics of Peripheral Arterial Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Diagnostics of Peripheral Arterial Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Diagnostics of Peripheral Arterial Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Diagnostics of Peripheral Arterial Disease players cover Viasonix, Koven Technology, Natus Medical, Huntleigh, Hokanson, CooperSurgical, Perimed, Atys Medical and Newman Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostics of Peripheral Arterial Disease market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Ankle-Brachial Index (ABI)
Ultrasonography
Angiography
Other

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Viasonix
Koven Technology
Natus Medical
Huntleigh
Hokanson
CooperSurgical
Perimed
Atys Medical
Newman Medical

Please note: The report will take approximately 2 business days to prepare and deliver.